These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evolving views in prion glycosylation: functional and pathological implications. Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773 [TBL] [Abstract][Full Text] [Related]
3. Prion protein aggregation and fibrillogenesis in vitro. Stöhr J Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001 [TBL] [Abstract][Full Text] [Related]
4. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity. Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026 [TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications. Singh J; Udgaonkar JB Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558 [TBL] [Abstract][Full Text] [Related]
6. α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein. Kobayashi A; Hirata T; Nishikaze T; Ninomiya A; Maki Y; Takada Y; Kitamoto T; Kinoshita T J Biol Chem; 2020 May; 295(22):7789-7798. PubMed ID: 32321762 [TBL] [Abstract][Full Text] [Related]
9. The role of rafts in the fibrillization and aggregation of prions. Pinheiro TJ Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049 [TBL] [Abstract][Full Text] [Related]
10. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein. Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870 [TBL] [Abstract][Full Text] [Related]
11. Cytoskeleton-dependent clustering of membrane-bound prion protein on the cell surface. Hackl S; Ng XW; Lu D; Wohland T; Becker CFW J Biol Chem; 2021; 296():100359. PubMed ID: 33539927 [TBL] [Abstract][Full Text] [Related]
12. Prion protein self-peptides modulate prion interactions and conversion. Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977 [TBL] [Abstract][Full Text] [Related]
13. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation. Bate C; Williams A J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283 [TBL] [Abstract][Full Text] [Related]
17. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes. Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436 [TBL] [Abstract][Full Text] [Related]
18. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism. Makarava N; Chang JC; Baskakov IV Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886 [TBL] [Abstract][Full Text] [Related]